MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DNAnexus Inc., the global leader in genome informatics and data management, today announced that the Stanford Center for Genomics and Personalized Medicine (SCGPM) has adopted the DNAnexus Platform on the Microsoft Azure cloud in order to bring enterprise-ready genomic analysis, data management, and collaborative research solutions to the center. The SCGPM, which supports researchers across nearly 80 laboratories, brought the two technologies together after working with both DNAnexus and Microsoft independently.
SCGPM seeks to advance genomic technology so that genetic and molecular profiling will become powerful tools routinely used to understand, detect, prevent, and treat complex diseases. To advance this goal, SCGPM had deployed both the DNAnexus Platform and the Azure cloud for different aspects of the core sequencing facility’s massive genomic processing and data management requirements. With this partnership, a distributed network of scientists and researchers now have secure and compliant access to petabytes worth of data through a simple web browser through DNAnexus on Azure. Each month SCGPM generates on average 7.7 trillion base-pairs of data, which if all this data came from a single DNA strand, it would stretch across the Golden Gate Bridge.
"By working closely with Microsoft though our relationship with Stanford and extending the DNAnexus Platform to Azure, we now offer our customers a tailored solution for incorporating Azure into state-of-the-art infrastructure for biomedical innovation,” said Richard Daly, CEO of DNAnexus.
"Microsoft is committed to advancing the field of genomics," according to David Heckerman, distinguished scientist and director of Microsoft Genomics. "We look forward to working together with DNAnexus to further accelerate global scientific discoveries.”
About DNAnexus
DNAnexus combines expertise in computing and bioinformatics to create the global network for genomics. The company operates in 31 countries, and spans a wide spectrum of industries — pharmaceutical and biotech, healthcare, clinical diagnostics, government, and research consortia — facilitating some of the most challenging and exciting opportunities in human health. The secure, scalable, and collaborative DNAnexus Platform combines out-of-the-box clinical compliance for the healthcare industry, streamlining communication between healthcare providers and reducing information silos for more efficient collaboration. For more information on DNAnexus, please visit www.dnanexus.com or follow the company @DNAnexus.
